What would be affected if an enteric coated tablet were cut in half?

Cutting an enteric-coated tablet in half would compromise its protective coating, which is designed to prevent the tablet from dissolving in the acidic environment of the stomach. This could lead to premature release of the active ingredient, potentially causing irritation to the stomach lining and reducing the effectiveness of the medication. Additionally, the altered dissolution profile may result in inconsistent dosing, affecting therapeutic outcomes.